AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
Abstract: DNA microarrays, which allow for the parallel analysis of thousands of genes, have become the most popular functional genomic tool in use today. Substantial data sets are currently being ...
There are two key things to know about the new Applied Biosystemsâ„¢ SwiftArrayStudioâ„¢ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
An international research team led by the University of Vienna has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can ...
Abstract: In feature selection research, simultaneous multi-class feature selection technologies are popular because they simultaneously select informative features for all classes. Recursive feature ...
Micron Biomedical today announced positive Phase 1/2 data from the first-ever clinical trial of microarray technology in children including infants as young as 9 months old. Successful Phase 1/2 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results